Citigroup Inc Alnylam Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 194,734 shares of ALNY stock, worth $63.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

194,734

Previous 86,897 124.1%

Holding current value

$63.2 Million

Previous $20.4 Million 157.16%

% of portfolio

0.03%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$233.07 - $290.7 $25.1 Million - $31.3 Million	107,837 Added 124.1%	194,734 $52.6 Million
Q4 2024 Feb 12, 2025	BUY	$232.27 - $300.43 $2.93 Million - $3.79 Million	12,626 Added 17.0%	86,897 $20.4 Million
Q3 2024 Nov 12, 2024	SELL	$233.81 - $287.01 $76.5 Million - $94 Million	-327,389 Reduced 81.51%	74,271 $20.4 Million
Q2 2024 Aug 12, 2024	BUY	$143.31 - $247.0 $36 Million - $62 Million	250,970 Added 166.55%	401,660 $97.6 Million
Q1 2024 May 10, 2024	BUY	$146.51 - $198.2 $11.4 Million - $15.4 Million	77,889 Added 106.99%	150,690 $22.5 Million
Q4 2023 Feb 09, 2024	SELL	$151.41 - $196.57 $1.01 Million - $1.32 Million	-6,698 Reduced 8.43%	72,801 $13.9 Million
Q3 2023 Nov 09, 2023	BUY	$170.77 - $211.65 $3.12 Million - $3.87 Million	18,295 Added 29.89%	79,499 $14.1 Million
Q2 2023 Aug 10, 2023	SELL	$185.01 - $212.05 $3.27 Million - $3.74 Million	-17,657 Reduced 22.39%	61,204 $11.6 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $21.4 Million - $27.7 Million	-117,400 Reduced 59.82%	78,861 $15.8 Million
Q4 2022 Feb 09, 2023	BUY	$185.53 - $241.31 $2.27 Million - $2.95 Million	12,231 Added 6.65%	196,261 $46.6 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $6.1 Million - $10.2 Million	44,038 Added 31.46%	184,030 $36.8 Million
Q2 2022 Aug 10, 2022	BUY	$120.42 - $169.29 $9.99 Million - $14 Million	82,983 Added 145.56%	139,992 $20.4 Million
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $1.56 Million - $2.14 Million	-12,301 Reduced 17.75%	57,009 $9.31 Million
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $268,379 - $352,025	-1,682 Reduced 2.37%	69,310 $11.8 Million
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $12.1 Million - $14.7 Million	70,992 New	70,992 $13.4 Million

Others Institutions Holding ALNY

# of Institutions

724

Shares Held

111M

Call Options Held

966K

Put Options Held

853K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $40B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account